Viewing Study NCT06126718


Ignite Creation Date: 2025-12-25 @ 4:58 AM
Ignite Modification Date: 2026-01-29 @ 3:04 PM
Study NCT ID: NCT06126718
Status: COMPLETED
Last Update Posted: 2025-06-24
First Post: 2023-11-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I Randomized, Open-label, Parallel-controlled, Pharmacokinetic and Safety Study of BR201 Injection Versus Cosentyx in Healthy Male Subjects
Sponsor: BioRay Pharmaceutical Co., Ltd.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Psoriasis View
Keywords: